Treat parkinson s in humans. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Substantia Nigra Lewy Bodies Dopaminergic Neurons Subthalamic Nucleus Brain Neurons Putamen Pedunculopontine Tegmental Nucleus Corpus Striatum Mesencephalon Globus Pallidus Mitochondria Basal Ganglia Cell Line Neostriatum Cells, Cultured Caudate Nucleus Inclusion Bodies Cell Line, Tumor PC12 Cells Cerebral Cortex

Organisms6

Mice, Inbred C57BL Rats, Sprague-Dawley Pan troglodytes Mice, Knockout Mice, Transgenic Hominidae

Diseases33

Parkinson Disease Parkinsonian Disorders Parkinson Disease, Secondary Multiple System Atrophy Neurodegenerative Diseases Lewy Body Disease MPTP Poisoning Gait Disorders, Neurologic Supranuclear Palsy, Progressive Disease Models, Animal Essential Tremor Gaucher Disease REM Sleep Behavior Disorder Nerve Degeneration Genetic Predisposition to Disease Hypokinesia Dementia Movement Disorders Dyskinesias Olfaction Disorders Alzheimer Disease Sleep Arousal Disorders Primary Dysautonomias Postmortem Changes Manganese Poisoning Dyskinesia, Drug-Induced Pure Autonomic Failure Deglutition Disorders Sweat Gland Diseases Parkinson Disease, Postencephalitic Disease Progression Sensation Disorders Hallucinations

Chemicals and Drugs56

alpha-Synuclein Antiparkinson Agents Levodopa Glucosylceramidase Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Oxidopamine Ubiquitin-Protein Ligases Tyrosine 3-Monooxygenase Oncogene Proteins Pergolide Carbidopa beta-Synuclein Neuroprotective Agents Maneb 1-Methyl-4-phenylpyridinium Dopamine Plasma Membrane Transport Proteins Dopamine Agents Tropanes Synucleins Dopamine Agonists Benzothiazoles tau Proteins Adrenergic Agents Nerve Tissue Proteins Rotenone Paraquat Intracellular Signaling Peptides and Proteins Amyloid Protein-Serine-Threonine Kinases Apomorphine Sympatholytics Receptors, Dopamine 3,4-Dihydroxyphenylacetic Acid Vesicular Monoamine Transport Proteins Proteasome Endopeptidase Complex Pemoline Selenoprotein W Chromogranin B Ubiquitin Thiazoles Cysteinyldopa Protein Kinases Dihydroxyphenylalanine Biological Markers Sodium Benzoate Selegiline Amyloid beta-Peptides Herbicides Neurotoxins Fungicides, Industrial Electron Transport Complex I Monoamine Oxidase Glial Cell Line-Derived Neurotrophic Factor Radiopharmaceuticals Mitochondrial Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Deep Brain Stimulation Dance Therapy Disease Models, Animal Gait Severity of Illness Index Treatment Outcome Case-Control Studies Positron-Emission Tomography Models, Biological Analysis of Variance Genetic Testing Genome-Wide Association Study Magnetic Resonance Imaging Risk Factors Double-Blind Method Stereotaxic Techniques DNA Mutational Analysis Neurologic Examination Cohort Studies Reproducibility of Results Follow-Up Studies Immunohistochemistry Reference Values Prospective Studies Electromyography Retrospective Studies Exercise Therapy Autopsy Blotting, Western Questionnaires Sensitivity and Specificity Physical Therapy Modalities Risk Assessment Disability Evaluation Activities of Daily Living Predictive Value of Tests

Psychiatry and Psychology23

Lewy Body Disease Dance Therapy REM Sleep Behavior Disorder Dementia Neuropsychological Tests Alzheimer Disease Apathy Sleep Arousal Disorders Cognition Disorders Psychomotor Performance Motor Skills Motor Activity Dreams Reality Therapy Task Performance and Analysis Introversion (Psychology)Cognition Mental Status Schedule Impulse Control Disorders Functional Laterality Behavior, Animal Psychiatric Status Rating Scales Hallucinations

Phenomena and Processes40

Postural Balance Mutation Gait Genetic Predisposition to Disease Time Factors Autophagy Genotype Oxidative Stress Polymorphism, Single Nucleotide Phenotype Movement Psychomotor Performance Dose-Response Relationship, Drug Mutation, Missense Motor Activity Aging Amino Acid Sequence Species Specificity Penetrance Gene Expression Regulation Protein Binding Proteolysis Genetic Variation Mitochondrial Degradation DNA Repeat Expansion Signal Transduction Functional Laterality Cell Death Base Sequence Heterozygote Sensitivity and Specificity Deglutition Gene Frequency Alleles Cell Survival Walking Apoptosis Locomotion Haplotypes Rotation

Disciplines and Occupations2

Immunohistochemistry Neurology

Anthropology, Education, Sociology and Social Phenomena3

Autopsy Walking Activities of Daily Living

Information Science4

Molecular Sequence Data Amino Acid Sequence Base Sequence Questionnaires

Health Care24

Severity of Illness Index Age of Onset Treatment Outcome Case-Control Studies Analysis of Variance Genetic Testing Genome-Wide Association Study Risk Factors Double-Blind Method Cohort Studies Reproducibility of Results Accidental Falls Follow-Up Studies Prospective Studies Refusal to Treat Retrospective Studies Age Factors Questionnaires Family Health Sensitivity and Specificity Risk Assessment Activities of Daily Living Environmental Exposure Predictive Value of Tests

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Parkinson Disease alpha-Synuclein Antiparkinson Agents Parkinsonian Disorders Parkinson Disease, Secondary Levodopa Glucosylceramidase Substantia Nigra Lewy Bodies Deep Brain Stimulation Multiple System Atrophy Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Dopaminergic Neurons Oxidopamine Subthalamic Nucleus Neurodegenerative Diseases Lewy Body Disease MPTP Poisoning Gait Disorders, Neurologic Supranuclear Palsy, Progressive Postural Balance Brain Dance Therapy Neurons Putamen Disease Models, Animal Ubiquitin-Protein Ligases Essential Tremor Mutation Gait Pedunculopontine Tegmental Nucleus Gaucher Disease REM Sleep Behavior Disorder Tyrosine 3-Monooxygenase Oncogene Proteins Pergolide Carbidopa Nerve Degeneration Corpus Striatum Genetic Predisposition to Disease beta-Synuclein Hypokinesia Dementia Time Factors Mesencephalon Movement Disorders Globus Pallidus Severity of Illness Index Neuroprotective Agents Mitochondria Age of Onset Maneb Neuropsychological Tests Treatment Outcome Case-Control Studies Dyskinesias Positron-Emission Tomography 1-Methyl-4-phenylpyridinium Olfaction Disorders Dopamine Plasma Membrane Transport Proteins Models, Biological Dopamine Agents Molecular Sequence Data Tropanes Synucleins Dopamine Agonists Analysis of Variance Alzheimer Disease Benzothiazoles Apathy Autophagy Genotype Mice, Inbred C57BL tau Proteins Oxidative Stress Polymorphism, Single Nucleotide Adrenergic Agents Sleep Arousal Disorders Cognition Disorders Genetic Testing Basal Ganglia Nerve Tissue Proteins Rotenone Primary Dysautonomias Postmortem Changes Genome-Wide Association Study Magnetic Resonance Imaging Cell Line Manganese Poisoning Dyskinesia, Drug-Induced Phenotype Pure Autonomic Failure Movement Psychomotor Performance Dose-Response Relationship, Drug Risk Factors Double-Blind Method Paraquat Intracellular Signaling Peptides and Proteins

No FAQ available that match "treat parkinson s in humans"